The SA Journal Diabetes & Vascular Disease Volume 20 No 2 (November 2023)

THE ENDURANCE ACE- i For further product information contact PHARMA DYNAMICS Email info@pharmadynamics.co.za CUSTOMER CARE LINE +27 21 707 7000 www.pharmadynamics.co.za PEARINDA 4, 8. Each tablet contains 4, 8 mg perindopril tert-butylamine respectively. S3 A41/7.1.3/0649, 0650. NAM NS2 10/7.1.3/0476, 0477. PEARINDA PLUS 4. Each tablet contains 4 mg perindopril tert-butylamine and 1,25 mg indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. PEARINDA PLUS 8. Each tablet contains 8 mg perindopril tert -butylamine and 2,5 mg indapamide. S3 A49/7.1.3/0013. NAM NS2 10/7.1.3/0477. For full prescribing information, refer to the professional information approved by SAHPRA. 1) Data on file. 2) Mourad JJ and Le Jeune S. Evaluation of high dose of perindopril/ indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Current Medical Research and Opinion 2009;25(9):2271-2280. 3) Telejko E, Perindopril arginine: Benefits of a new salt of the ACE inhibitor perindopril. Current Medical Research and Opinion 2007;23(5):953-960. PAD1044/05/2023 ATHLETE: AJ Calitz – CHAMPION TRAIL RUNNER Mourad JJ and Le Jeune S. reported that Perindopril/Indapamide has shown2: • Incremental dose e cacy • Increased BP responder rates • Proven outcomes PERINDOPRIL TERT-BUTYLAMINE 8 mg IS EQUIVALENT TO PERINDOPRIL ARGININE 10 mg3 PERINDOPRIL TERT-BUTYLAMINE/ INDAPAMIDE 8/2,5 mg FORMULARY LISTINGS1 DISCOVERY HEALTH Exec/Comp Core/Saver/Priority Keycare MPL* MMAP MRP MMI 4 mg 8 mg 4 mg/ 1,25 mg 8 mg/ 2,5 mg                         * All plans excluding the low chronic and restrictive formulars.

RkJQdWJsaXNoZXIy NDIzNzc=